Position in PFE
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$680,693
-$96,645 QoQ
Shares Held
28,268
+2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#1,550
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cornell Pochily Investment Advisors, Inc. holds $19,372,779 across 8 Drug Manufacturers - General names. PFE ranks #8 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
24,344 | $6,125,924 | |
| 2 | JNJ |
Johnson & Johnson
|
18,975 | $4,819,080 | |
| 3 | AMGN |
Amgen Inc
|
7,009 | $2,538,099 | |
| 4 | LLY |
ELI LILLY & Co
|
1,708 | $2,048,626 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
10,724 | $1,354,870 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,019 | $1,030,441 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
13,451 | $775,046 | |
| 8 | PFE |
Pfizer Inc
This page
|
28,268 | $680,693 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $680,693 | 28,268 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $777,338 | 27,683 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $724,390 | 29,092 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $769,572 | 30,203 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $718,449 | 29,639 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $753,028 | 29,717 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $844,609 | 31,836 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,017,848 | 35,171 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $415,698 | 14,857 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $368,409 | 13,276 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $384,548 | 13,357 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $508,695 | 15,336 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $606,430 | 16,533 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $674,546 | 16,533 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $929,442 | 18,139 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $808,641 | 18,479 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $1,043,566 | 19,904 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $1,030,430 | 19,904 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $1,194,227 | 20,224 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $888,973 | 20,669 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $747,564 | 19,090 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $626,308 | 17,287 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $575,597 | 15,637 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $544,443 | 14,835 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $466,662 | 14,271 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $465,674 | 14,267 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||